Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Psychopharmacology|January 15, 1999
Abuse liability of flunitrazepam among methadone-maintained patientsM Farré, M T Terán, P N Roset, et al.
The European Journal of Neuroscience|May 22, 2001
Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effectO Valverde, F Noble, F Beslot, et al.
Current HIV Research|December 29, 2010
Use of highly active antiretroviral therapy is increasing in HIV positive severe drug usersG Vallecillo, A Sanvisens, E Martinez, et al.
AIDS and Behavior|January 27, 2018
Trends in AIDS Mortality, Retention in Opioid Agonist Therapy, and HIV RNA Suppression in HIV-Infected People Who Injected Drugs from 2000 to 2015G Vallecillo, M J Robles, X Durán, et al.
Psychopharmacology|January 1, 1991
Influence of different benzodiazepines on the experimental morphine abstinence syndromeR Maldonado, J A Micó, O Valverde, et al.
Drug and Alcohol Dependence|May 30, 2001
Differences in severity of heroin dependence by route of administration: the importance of length of heroin useG Barrio, L De La Fuente, C Lew, et al.
Physics in Medicine and Biology|January 21, 2016
On the development of a comprehensive MC simulation model for the Gamma Knife Perfexion radiosurgery unitE P Pappas, A Moutsatsos, E Pantelis, et al.
Drug and Alcohol Dependence|August 26, 1999
Methadone treatment in Spain, 1994A Domingo-Salvany, K Pérez, M Torrens, et al.
The Journal of School Health|August 12, 2011
Frequent fliers, school phobias, and the sick student: school health personnel's perceptions of students who refuse schoolAnna M Torrens Armstrong, Kelli R McCormack Brown, Roger Brindley, et al.
British Journal of Pharmacology|March 1, 1995
Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308R Maldonado, O Valverde, B Ducos, et al.
Pageof 11